Sony, Olympus set up medical joint venture

Sony, Olympus set up medical joint venture

TOKYO, Japan - Toru Katsumoto (L), president of Sony Olympus Medical Solutions Inc., shakes hands with Takashi Fukaya, executive vice president of the new company, at a press conference in Tokyo on April 16, 2013. Sony Olympus Medical Solutions is a joint venture formally established the same day by merging the medical businesses of Sony Corp. and Olympus Corp., with an eye to marketing new endoscopes and other medical equipment.

  • Product Code
  • ILEA001181431
  • Registered date
  • 2013/4/16 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 3204 × 2525 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 735.73(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Research to start on blood tests to detect 13 cancer types

    Research to start on blood tests to detect 13 cancer types

    TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
      Novartis management replaced

      Novartis management replaced

      TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
        Novartis management replaced

        Novartis management replaced

        TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
          Novartis management replaced

          Novartis management replaced

          TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
            Food chain president shot dead

            Food chain president shot dead

            KYOTO, Japan - Photo taken in Kyoto's Yamashina Ward on Dec. 19, 2013, shows the site (L back) where Takayuki Ohigashi, president of Ohsho Food Service Corp., was shot earlier the same day. The president of the company, which operates a Chinese dumpling restaurant chain under the "Gyoza no Ohsho" brand in Japan, was found lying in a parking lot in front of the company's head office (seen at the right) just before 7 a.m. and was confirmed dead after being taken to hospital, according to the Kyoto prefectural police.
              Myanmar's president in Japan

              Myanmar's president in Japan

              TOKYO, Japan - Myanmar's President Thein Sein (L) and Japanese Prime Minister Shinzo Abe shake hands before holding talks at Abe's office in Tokyo on Dec. 15, 2013.
                Amari to miss key TPP talks due to cancer treatment

                Amari to miss key TPP talks due to cancer treatment

                TOKYO, Japan - Akira Amari, Japan's minister in charge of the Trans-Pacific Partnership free trade talks, announces at a press conference at the Cabinet Office in Tokyo on Dec. 5, 2013, that he will not be able to attend a TPP ministerial negotiating session starting Dec. 7 in Singapore, as he has been diagnosed with tongue cancer. Tokyo will send Amari's deputy, Yasutoshi Nishimura, senior vice minister of the Cabinet Office, instead to the four-day meeting.
                  Online sales of over-the-counter drugs

                  Online sales of over-the-counter drugs

                  TOKYO, Japan - Health, Labor and Welfare Minister Norihisa Tamura holds a press conference at the ministry in Tokyo on Nov. 6, 2013. The government said the same day that online sales of drugs moving from prescription to over-the-counter status will be banned for three years from the point of such movement in principle under new rules that could take effect next spring.
                    Japan Tobacco to undertake drastic restructuring

                    Japan Tobacco to undertake drastic restructuring

                    TOKYO, Japan - Japan Tobacco Co. Vice President Akira Saeki speaks at a news conference in Tokyo on Oct. 30, 2013, as the company said it will close four of its nine cigarette manufacturing-related factories in Japan and a vending machine production base, most of them in March 2015, and cut 1,600 jobs, or about 20 percent of the employees in its tobacco business, due to falling sales.
                      Novartis scandal

                      Novartis scandal

                      TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, speaks in a press conference in Tokyo on Oct. 3, 2013. At right is Yoshiyasu Ninomiya, president of Novartis Pharma K.K., a Japanese unit of Novartis AG. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.